Pilsicainide
Alternative Names: Alisrythm; DU 6552; Pilsinic; Pilzicainide; Rizmsat; Rizumcote; SUN 1165; SUN 1165i; Sunrhythm; Sunrythm; TatsupilljinLatest Information Update: 05 Nov 2023
At a glance
- Originator Asubio Pharma
- Developer Asubio Pharma; Daiichi Sankyo Company
- Class 2 ring heterocyclic compounds; Acetanilides; Class Ic antiarrhythmics; Pyrrolidines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Arrhythmias
Most Recent Events
- 31 Dec 2007 Launched for Arrhythmias in South Korea (PO)
- 31 Dec 2007 Registered for Arrhythmias in South Korea (PO)
- 01 Apr 2007 Daiichi Asubio Pharma is now called Asubio Pharma